Penelope Markham
Corporate Officer/Principal at BIOVIE INC.
Net worth: 25 308 $ as of 2024-03-30
Profile
Penelope Markham founded Influx, Inc. in 1997, where she worked as Research Director from 1997 to 2003.
Dr. Markham also currently works at BioVie, Inc., as Executive Vice President-Liver Disease Research from 2021.
Dr. Markham received her doctorate degree from Rush University, graduate degree from the University of Strathclyde, and undergraduate degree from University College Cork.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOVIE INC. CLASS A
0.08% | 2023-02-15 | 47,841 ( 0.08% ) | 25 308 $ | 2024-03-30 |
Penelope Markham active positions
| Companies | Position | Start |
|---|---|---|
| BIOVIE INC. | Corporate Officer/Principal | 2021-04-26 |
Former positions of Penelope Markham
| Companies | Position | End |
|---|---|---|
Influx, Inc.
 Influx, Inc. Pharmaceuticals: MajorHealth Technology Influx, Inc. discovers and develops antibiotics for difficult-to-treat infections. The company is headquartered in Chicago, IL. | Founder | 2002-12-31 |
Training of Penelope Markham
| Rush University | Doctorate Degree |
| University of Strathclyde | Graduate Degree |
| University College Cork | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOVIE INC. | Health Technology |
| Private companies | 1 |
|---|---|
Influx, Inc.
Influx, Inc. Pharmaceuticals: MajorHealth Technology Influx, Inc. discovers and develops antibiotics for difficult-to-treat infections. The company is headquartered in Chicago, IL. | Health Technology |
- Stock Market
- Insiders
- Penelope Markham
